Evidence map›Paper›PMID 34966390›Full record

ArticleFrontiers in immunology2021

Donor NK and T Cells in the Periphery of Lung Transplant Recipients Contain High Frequencies of Killer Cell Immunoglobulin-Like Receptor-Positive Subsets.

Anna-Maria Hitz, Kim-Alina Bläsing, Bettina Wiegmann, Ramon Bellmàs-Sanz, Evgeny Chichelnitskiy, Franziska Wandrer, Lisa-Marie Horn, Christine Neudörfl, Jana Keil, Kerstin Beushausen and 11 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 1 country.

Anna-Maria HitzInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.
Kim-Alina BläsingInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.
Bettina WiegmannDepartment of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Ramon Bellmàs-SanzInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.
Evgeny ChichelnitskiyInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.
Franziska WandrerInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.
Lisa-Marie HornInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.
Christine NeudörflInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.
Jana KeilInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.
Kerstin BeushausenInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.
Fabio IusDepartment of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Wiebke SommerDepartment of Cardiac Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Murat AvsarDepartment of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Christian KühnDepartment of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Igor TudoracheDepartment of Cardiac Surgery, University Hospital of Duesseldorf, Duesseldorf, Germany.
Jawad SalmanDepartment of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Thierry SiemeniDepartment of Cardiothoracic Surgery, University Hospital Jena, Jena, Germany.
Axel HaverichDepartment of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Gregor WarneckeDepartment of Cardiac Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Christine S FalkInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.
Jenny F KühneInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.
Medizinische Hochschule Hannover · DEDüsseldorf University Hospital · DEGerman Center for Lung Research · DEHeidelberg University · DEJena University Hospital · DEUniversity Hospital Heidelberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: For end-stage lung diseases, double lung transplantation (DLTx) is the ultimate curative treatment option. However, acute and chronic rejection and chronic dysfunction are major limitations in thoracic transplantation medicine. Thus, a better understanding of the contribution of immune responses early after DLTx is urgently needed. Passenger cells, derived from donor lungs and migrating into the recipient periphery, are comprised primarily by NK and T cells. Here, we aimed at characterizing the expression of killer cell immunoglobulin-like receptors (KIR) on donor and recipient NK and T cells in recipient blood after DLTx. Furthermore, we investigated the functional status and capacity of donor Methods: Peripheral blood samples of 51 DLTx recipients were analyzed pre Tx and at T0, T24 and 3wk post Tx for the presence of HLA-mismatched donor NK and T cells, their KIR repertoire as well as activation status using flow cytometry. Results: Within the first 3 weeks after DLTx, donor NK and T cells were detected in all patients with a peak at T0. An increase of the KIR2DL/S1-positive subset was found within the donor NK cell repertoire. Moreover, donor NK cells showed significantly higher frequencies of KIR2DL/S1-positive cells (p<0.01) 3wk post DLTx compared to recipient NK cells. This effect was also observed in donor KIR Conclusion: Higher frequencies of donor NK and T cells expressing KIR compared to recipient NK and T cells argue for their origin in the lung as a part of a highly specialized immunocompetent compartment. Despite KIR expression, higher activation levels of donor NK and T cells in the periphery of recipients suggest their pre-activation during the

Indexed as

Lung TransplantationAdultCell DegranulationCoculture TechniquesCytotoxicity, ImmunologicFemaleFlow CytometryHumansImmunophenotypingInterleukin-2 Receptor alpha SubunitK562 CellsKiller Cells, NaturalLungMaleMiddle AgedPhenotypeIL2RA protein, humanInterleukin-2 Receptor alpha SubunitKIR2DL3 protein, humanKIR3DL1 protein, humanReceptors, KIRReceptors, KIR2DL3Receptors, KIR3DL1cold ischemic timekiller cell immunoglobulin-like receptorlung transplantationNK cellspassenger leukocytesprimary graft dysfunctionT cells

Identifiers

PMID34966390
PMCPMC8710687
OpenAlexW4200258476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.